Tumor Volume Predicts High-Risk Patients and Guides Initial Chemoradiotherapy for Early Cervical Cancer
We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who re...
Saved in:
Published in | Frontiers in oncology Vol. 11; p. 640846 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
27.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student’s t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01–13.5 mm and 105–27,990 mm
3
, respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm
3
as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm
3
), which could be an indication of initial chemoradiotherapy for early cervical cancer. |
---|---|
AbstractList | We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student’s t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01–13.5 mm and 105–27,990 mm
3
, respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm
3
as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm
3
), which could be an indication of initial chemoradiotherapy for early cervical cancer. We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student's t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01-13.5 mm and 105-27,990 mm , respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm ), which could be an indication of initial chemoradiotherapy for early cervical cancer. We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student’s t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01–13.5 mm and 105–27,990 mm3, respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm3 as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm3), which could be an indication of initial chemoradiotherapy for early cervical cancer. We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student's t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01-13.5 mm and 105-27,990 mm3, respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm3 as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm3), which could be an indication of initial chemoradiotherapy for early cervical cancer.We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student's t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01-13.5 mm and 105-27,990 mm3, respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm3 as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm3), which could be an indication of initial chemoradiotherapy for early cervical cancer. |
Author | Zhang, Jingjing Yang, Jiaxin Shen, Keng Cao, Dongyan Xue, Huadan He, Yonglan |
AuthorAffiliation | 2 Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China 3 Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China 1 Department of Gynecology and Obstetrics, The First Affiliated Hospital, Sun Yat-sen University , Guangzhou , China |
AuthorAffiliation_xml | – name: 1 Department of Gynecology and Obstetrics, The First Affiliated Hospital, Sun Yat-sen University , Guangzhou , China – name: 2 Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China – name: 3 Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China |
Author_xml | – sequence: 1 givenname: Jingjing surname: Zhang fullname: Zhang, Jingjing – sequence: 2 givenname: Dongyan surname: Cao fullname: Cao, Dongyan – sequence: 3 givenname: Jiaxin surname: Yang fullname: Yang, Jiaxin – sequence: 4 givenname: Keng surname: Shen fullname: Shen, Keng – sequence: 5 givenname: Yonglan surname: He fullname: He, Yonglan – sequence: 6 givenname: Huadan surname: Xue fullname: Xue, Huadan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33987083$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kk1r3DAQhkVJadI0956Kj714o2_Zl0JZ0mQh0FDS0psYfXhXqdfaSnZg_33lbhKSQuciMfPOM0LzvkVHQxw8Qu8JXjDWtOddHOyCYkoWkuOGy1fohFLG65azn0fP7sfoLOc7XEIKTDB7g44ZaxuFG3aC1rfTNqbqR-ynra9uknfBjrm6CutN_S3kX9UNjMEPJQWDqy6n4HyuVkMYA_TVcuNLM7gQx41PsNtXXWFdQOr31dKn-2BnEQzWp3fodQd99mcP5yn6_uXidnlVX3-9XC0_X9eWSzrWXEklrbScUEsJxQ4ctEZYwMp2nQRjhOMtpo0CoxpPVSkQwzrTUS6MlewUrQ5cF-FO71LYQtrrCEH_TcS01pDGYHuvwanGgHWsBBdOgXCdAmuAYcEEs4X16cDaTWbrnS3fkKB_AX1ZGcJGr-O9bgghuBEF8PEBkOLvyedRb0O2vu9h8HHKmgraEKVaSYv0w_NZT0MeN1UE-CCwKeacfPckIVjPftCzH_TsB33wQ2mR_7TYMJZ1xvm1of9_4x-_Gbyq |
CitedBy_id | crossref_primary_10_1186_s41205_025_00256_z crossref_primary_10_3389_fonc_2021_690275 |
Cites_doi | 10.1016/s0140-6736(97)02250-2 10.1097/IGC.0b013e3182a16997 10.7150/jca.50752 10.1136/ijgc-2019-000890 10.1093/jrr/rraa004 10.1016/j.ijgo.2009.02.009 10.1111/jog.13282 10.3857/roj.2012.30.2.70 10.1159/000353899 10.1016/S0959-8049(01)00353-7 10.1002/ijgo.12611 10.1097/igc.0000000000001327 10.6004/jnccn.2019.0001 10.3322/caac.20107 10.1016/s0140-6736(18)32470-x 10.1006/gyno.2001.6267 10.1007/s11912-017-0614-5 10.1006/gyno.2001.6493 10.1097/igc.0000000000001216 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue. Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue 2021 Zhang, Cao, Yang, Shen, He and Xue |
Copyright_xml | – notice: Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue. – notice: Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue 2021 Zhang, Cao, Yang, Shen, He and Xue |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fonc.2021.640846 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2234-943X |
ExternalDocumentID | oai_doaj_org_article_ad78bacd333345d7a5df7acba305353c PMC8111085 33987083 10_3389_fonc_2021_640846 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EJD EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-47676c6c412c2120dada9b5ca07cff6abb5d490287ab78e27a071b3fbf245bc63 |
IEDL.DBID | M48 |
ISSN | 2234-943X |
IngestDate | Wed Aug 27 00:47:49 EDT 2025 Thu Aug 21 14:04:35 EDT 2025 Fri Jul 11 01:50:39 EDT 2025 Thu Apr 03 07:05:42 EDT 2025 Tue Jul 01 04:38:44 EDT 2025 Thu Apr 24 22:59:05 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | adverse pathological risk factor predictive value tumor volume cervical cancer tumor-free margin high-risk patients |
Language | English |
License | Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-47676c6c412c2120dada9b5ca07cff6abb5d490287ab78e27a071b3fbf245bc63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Alberto Farolfi, Istituto Scientifico Romagnolo per lo Studio e il Trattamento dei Tumori (IRCCS), Italy This article was submitted to Gynecological Oncology, a section of the journal Frontiers in Oncology Reviewed by: Patrice Mathevet, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland; Benedetta Guani, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fonc.2021.640846 |
PMID | 33987083 |
PQID | 2528177962 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ad78bacd333345d7a5df7acba305353c pubmedcentral_primary_oai_pubmedcentral_nih_gov_8111085 proquest_miscellaneous_2528177962 pubmed_primary_33987083 crossref_primary_10_3389_fonc_2021_640846 crossref_citationtrail_10_3389_fonc_2021_640846 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-04-27 |
PublicationDateYYYYMMDD | 2021-04-27 |
PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-27 day: 27 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in oncology |
PublicationTitleAlternate | Front Oncol |
PublicationYear | 2021 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Dostalek (B10) 2020; 30 Chen (B11) 2002; 23 Jemal (B2) 2011; 61 Zhu (B16) 2020; 11 Pecorelli (B3) 2009; 105 Bhatla (B4) 2018; 143 Landoni (B8) 1997; 350 Takekuma (B9) 2017; 43 Chen (B12) 2018; 28 Zigras (B14) 2017; 19 Byun (B13) 2013; 23 Covens (B17) 2002; 84 Koh (B7) 2019; 17 Wagenaar (B5) 2001; 82 Kim (B19) 2012; 30 Cibula (B6) 2018; 28 Cohen (B1) 2019; 393 Yamamoto (B15) 2020; 61 Meirovitz (B18) 2013; 76 |
References_xml | – volume: 350 year: 1997 ident: B8 article-title: Randomised Study of Radical Surgery Versus Radiotherapy for Stage Ib-Iia Cervical Cancer publication-title: Lancet doi: 10.1016/s0140-6736(97)02250-2 – volume: 23 year: 2013 ident: B13 article-title: Three-Dimensional Transvaginal Ultrasonography for Locally Advanced Cervical Cancer publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0b013e3182a16997 – volume: 11 year: 2020 ident: B16 article-title: The Clinical and Prognostic Implication of Deep Stromal Invasion in Cervical Cancer Patients Undergoing Radical Hysterectomy publication-title: J Cancer doi: 10.7150/jca.50752 – volume: 30 year: 2020 ident: B10 article-title: Oncologic Outcome After Completing or Abandoning (Radical) Hysterectomy in Patients With Cervical Cancer and Intraoperative Detection of Lymph Node Positivity; ABRAX (Abandoning Rad Hyst in Cervix Cancer) publication-title: Int J Gynecol Cancer doi: 10.1136/ijgc-2019-000890 – volume: 61 year: 2020 ident: B15 article-title: Clinical Experience of Pelvic Radiotherapy or Chemoradiotherapy for Postoperative Uterine Cervical Cancer Using Intensity-Modulated Radiation Therapy publication-title: J Radiat Res doi: 10.1093/jrr/rraa004 – volume: 105 year: 2009 ident: B3 article-title: Revised FIGO Staging for Carcinoma of the Cervix publication-title: Int J Gynaecol Obstet doi: 10.1016/j.ijgo.2009.02.009 – volume: 43 year: 2017 ident: B9 article-title: The Issues Regarding Postoperative Adjuvant Therapy and Prognostic Risk Factors for Patients With Stage I-II Cervical Cancer: A Review publication-title: J Obstet Gynaecol Res doi: 10.1111/jog.13282 – volume: 30 year: 2012 ident: B19 article-title: Method of Tumor Volume Evaluation Using Magnetic Resonance Imaging for Outcome Prediction in Cervical Cancer Treated With Concurrent Chemotherapy and Radiotherapy publication-title: Radiat Oncol J doi: 10.3857/roj.2012.30.2.70 – volume: 76 year: 2013 ident: B18 article-title: Is Radical Hysterectomy Necessary in Early Cervical Cancer publication-title: Gynecol Obstet Invest doi: 10.1159/000353899 – volume: 23 year: 2002 ident: B11 article-title: Correlation of Three-Dimensional Tumor Volumetry With Cervical Cancer Prognostic Parameters publication-title: Eur J Gynaecol Oncol doi: 10.1016/S0959-8049(01)00353-7 – volume: 143 start-page: 22 year: 2018 ident: B4 article-title: Cancer of the Cervix Uteri publication-title: Int J Gynaecol Obstet doi: 10.1002/ijgo.12611 – volume: 28 year: 2018 ident: B12 article-title: Tumor Size At Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens publication-title: Int J Gynecol Cancer doi: 10.1097/igc.0000000000001327 – volume: 17 start-page: 64 year: 2019 ident: B7 article-title: Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology publication-title: J Natl Compr Canc Netw doi: 10.6004/jnccn.2019.0001 – volume: 61 start-page: 69 year: 2011 ident: B2 article-title: Global Cancer Statistics publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 – volume: 393 year: 2019 ident: B1 article-title: Cervical Cancer publication-title: Lancet doi: 10.1016/s0140-6736(18)32470-x – volume: 82 year: 2001 ident: B5 article-title: Tumor Diameter and Volume Assessed by Magnetic Resonance Imaging in the Prediction of Outcome for Invasive Cervical Cancer publication-title: Gynecol Oncol doi: 10.1006/gyno.2001.6267 – volume: 19 start-page: 51 year: 2017 ident: B14 article-title: Early Cervical Cancer: Current Dilemmas of Staging and Surgery publication-title: Curr Oncol Rep doi: 10.1007/s11912-017-0614-5 – volume: 84 year: 2002 ident: B17 article-title: How Important is Removal of the Parametrium At Surgery for Carcinoma of the Cervix publication-title: Gynecol Oncol doi: 10.1006/gyno.2001.6493 – volume: 28 year: 2018 ident: B6 article-title: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer publication-title: Int J Gynecol Cancer doi: 10.1097/igc.0000000000001216 |
SSID | ssj0000650103 |
Score | 2.2782834 |
Snippet | We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 640846 |
SubjectTerms | adverse pathological risk factor cervical cancer high-risk patients Oncology predictive value tumor volume tumor-free margin |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaqHlAviEKB8JKReuGQ7sbvHKGiFKRWFWpRb5afsAKyaLN76L9nJk5XuxWCCznGTmJ5vow_a8bfEHIoDIsc_qQ6Ji5r4XWo2xxMrXyTW5EMggqzLc7V6ZX4dC2vN0p9YU5YkQcuEzdxURvvQuRwCRm1kzFrF7zjqEzCA3pfWPM2NlPFB0ssYFDikrALayd53qFiIWuOlJga5Lsb69Ag1_8njnk3VXJj7Tl5QO6PpJG-LYPdJzupe0junY1h8Ufk6-Xq53xBvwyehl4ssGHZU8zhqD_P-u_0oqin9tR1kX5YzWLq6UdMG4K3omQA4CDOxrNYNxR4LB2Ej-nx4EmwE4JjcUCuTt5fHp_WYwWFOgjFlrXQSquggmhYgDVqGl10rZfBTXXIWTnvZRSo36Kd1yYxDQ2N59lnJqQPij8mu928S08JbRJwMQ90RKkosD4H-Aank5A8Bw2ktyKT2_m0YZQXxyoXPyxsM9ACFi1g0QK2WKAib9ZP_CrSGn_p-w5NtO6HotjDDYCKHaFi_wWViry-NbCFnwgjI65L81VvmWSm0bpVrCJPisHXn-K8BZ9meEX0FhS2xrLd0s2-DULdpsFDFvLZ_xj8c7KH84GBLKZfkN3lYpVeAh9a-lcD9H8DLDUKdQ priority: 102 providerName: Directory of Open Access Journals |
Title | Tumor Volume Predicts High-Risk Patients and Guides Initial Chemoradiotherapy for Early Cervical Cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33987083 https://www.proquest.com/docview/2528177962 https://pubmed.ncbi.nlm.nih.gov/PMC8111085 https://doaj.org/article/ad78bacd333345d7a5df7acba305353c |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkapeEG_Mo1okLhzcxvt0DghBRVuQiirUoNxW-2wjit3aiUT_PTO2EwiKOJCDD9ld29p5e2a_IeS1KFngIEl5iFzmwmmfj5Mvc-WKNBaxRKbCaosv6ngiPk_l9Pfx6GED242hHfaTmjSXez-vb96BwL_FiBPs7X6qKwQjZMWeEiOwp7fJHbBLGvsZnAzOfq-XJTY16HOVGxfukG3OIQgflXzNTHVo_ptc0L8rKf8wTYf3yN3Bp6Tveya4T27F6gHZPhmy5g_J-dniR93Qb50ioqcNDsxbiiUe-ddZ-52e9uCqLbVVoEeLWYgt_YRVRXBXRBQANgmz4ajWDQU3l3a4yPSgUzQ4CXmneUQmhx_PDo7zocFC7oVi81xopZVXXhTMgwkbBRvs2ElvR9qnpKxzMgiEd9HW6TIyDQOF48klJqTzij8mW1VdxaeEFhFcNQfeilJBYPsOUB1WRyF58hp84ozsL_fT-AF9HJtgXBqIQpAYBolhkBimJ0ZG3qxWXPXIG_-Y-wFJtJqHmNndH3VzbgYRNDbo0lkfOPyEDNrKkLT1znLEuOE-I6-WBDYgY5g4sVWsF61hkpWF1mPFMvKkJ_jqUUuGyYheY4W1d1kfqWYXHY53WeAZDPnsv1c-Jzu4CZjcYvoF2Zo3i_gSfKS52-2-LcD1aFrsdmLwCzRSE4I |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+Volume+Predicts+High-Risk+Patients+and+Guides+Initial+Chemoradiotherapy+for+Early+Cervical+Cancer&rft.jtitle=Frontiers+in+oncology&rft.au=Zhang%2C+Jingjing&rft.au=Cao%2C+Dongyan&rft.au=Yang%2C+Jiaxin&rft.au=Shen%2C+Keng&rft.date=2021-04-27&rft.pub=Frontiers+Media+S.A&rft.eissn=2234-943X&rft.volume=11&rft_id=info:doi/10.3389%2Ffonc.2021.640846&rft_id=info%3Apmid%2F33987083&rft.externalDocID=PMC8111085 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon |